AKBA combined with doxorubicin inhibits proliferation and metastasis of triple-negative breast cancer MDA-MB-231 cells and xenograft growth in nude mice
Objective To investigate the synergistic inhibitory effects of AKBA and doxorubicin on malignant phenotype of triple-negative breast cancer(TNBC)MDA-MB-231 cells.Methods CCK-8 assay was used to determine the 48-h IC50 of AKBA and doxorubicin in MDA-MB-231 cells,and SynergyFinder was employed to calculate the synergistic index and the optimal concentrations of the two agents.MDA-MB-231 cells treated with AKBA(22.5 μmol/L),doxorubicin(0.84 μmol/L)or their combination were examined for changes in cell proliferation,migration,invasion and apoptosis using Transwell migration,scratch assay,clone generation,RT-qPCR and Western blotting.Network pharmacology analysis was conducted to identify the downstream targets of AKBA in TNBC.In nude mouse models bearing subcutaneous MDA-MB-231 cell xenografts,the effects of normal saline,AKBA(50 mg/kg),doxorubicin(2.5 mg/kg),and AKBA combined with doxorubicin on xenograft growth and histopathology were observed.Results The IC50 of AKBA and doxorubicin in MDA-MB-231 cells at 48 h was 45.15±0.97 μmol/L and 0.42±0.99 μmol/L,respectively.SynergyFinder confirmed the synergistic effect of AKBA and ADR with a ZIP＞10.The combined treatment with AKBA and doxorubicin significantly inhibited the proliferation,migration and invasion,promoted apoptosis of MDA-MB-231 cells,and effectively suppressed xenograft growth in nude mice.Network pharmacology analysis predicted that AKBA affects the progression of TNBC through its downstream target AKBA.Conclusion AKBA combined with doxorubicin inhibits proliferation,migration and invasion,promotes apoptosis of MDA-MB-231 cells and suppresses MDA-MB-231 cell xenograft growth in nude mice.The combined use of AKBA can attenuate the toxic effects of doxorubicin in nude mice.
AKBAacetyl-11-keto-β-boswellic acidtriple-negative breast cancerdoxorubicin
万方数据
维普
